Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Seeger

Showing results (381-390 of 454) with videos related to

Pageof 46
Sort By:
The Journal of Laboratory and Clinical Medicine|December 26, 2001
Cellular pathophysiology and therapy of pulmonary hypertensionH Olschewski, F Rose, E Grünig, et al.
Infection and Immunity|February 20, 1999
Role of Listeria monocytogenes exotoxins listeriolysin and phosphatidylinositol-specific phospholipase C in activation of human neutrophilsU Sibelius, E C Schulz, F Rose, et al.
Pulmonary Circulation|September 30, 2016
NADPH oxidase 4 is not involved in hypoxia-induced pulmonary hypertensionC Veith, S Kraut, J Wilhelm, et al.
Thorax|November 18, 2000
Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapyR Schulz, D Schmidt, A Blum, et al.
Infection and Immunity|February 13, 2001
Human endothelial cell activation and mediator release in response to Listeria monocytogenes virulence factorsF Rose, S A Zeller, T Chakraborty, et al.
Der Anaesthesist|August 6, 2016
[Pulmonary hypertension : What is new in therapy?]N Sommer, M Hecker, K Tello, et al.
American Journal of Respiratory Cell and Molecular Biology|August 18, 2001
Urodilatin, a natriuretic peptide stimulating particulate guanylate cyclase, and the phosphodiesterase 5 inhibitor dipyridamole attenuate experimental pulmonary hypertension: synergism upon coapplicationR T Schermuly, N Weissmann, B Enke, et al.
Clinical and Experimental Immunology|May 26, 1999
Expression of mucosa-related integrin alphaEbeta7 on alveolar T cells in interstitial lung diseasesJ Lohmeyer, J Friedrich, F Grimminger, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 30, 2004
Modified polyethylenimines as non viral gene delivery systems for aerosol therapy: effects of nebulization on cellular uptake and transfection efficiencyL A Dailey, E Kleemann, T Merdan, et al.
The Journal of Experimental Medicine|October 1, 1994
Endotoxin "priming" potentiates lung vascular abnormalities in response to Escherichia coli hemolysin: an example of synergism between endo- and exotoxinD Walmrath, H A Ghofrani, S Rosseau, et al.
Pageof 46

Showing results (381-390 of 454) with videos related to

Sort By:
Pageof 46
The Journal of Laboratory and Clinical Medicine|December 26, 2001
Cellular pathophysiology and therapy of pulmonary hypertensionH Olschewski, F Rose, E Grünig, et al.
Infection and Immunity|February 20, 1999
Role of Listeria monocytogenes exotoxins listeriolysin and phosphatidylinositol-specific phospholipase C in activation of human neutrophilsU Sibelius, E C Schulz, F Rose, et al.
Pulmonary Circulation|September 30, 2016
NADPH oxidase 4 is not involved in hypoxia-induced pulmonary hypertensionC Veith, S Kraut, J Wilhelm, et al.
Thorax|November 18, 2000
Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapyR Schulz, D Schmidt, A Blum, et al.
Infection and Immunity|February 13, 2001
Human endothelial cell activation and mediator release in response to Listeria monocytogenes virulence factorsF Rose, S A Zeller, T Chakraborty, et al.
Der Anaesthesist|August 6, 2016
[Pulmonary hypertension : What is new in therapy?]N Sommer, M Hecker, K Tello, et al.
American Journal of Respiratory Cell and Molecular Biology|August 18, 2001
Urodilatin, a natriuretic peptide stimulating particulate guanylate cyclase, and the phosphodiesterase 5 inhibitor dipyridamole attenuate experimental pulmonary hypertension: synergism upon coapplicationR T Schermuly, N Weissmann, B Enke, et al.
Clinical and Experimental Immunology|May 26, 1999
Expression of mucosa-related integrin alphaEbeta7 on alveolar T cells in interstitial lung diseasesJ Lohmeyer, J Friedrich, F Grimminger, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 30, 2004
Modified polyethylenimines as non viral gene delivery systems for aerosol therapy: effects of nebulization on cellular uptake and transfection efficiencyL A Dailey, E Kleemann, T Merdan, et al.
The Journal of Experimental Medicine|October 1, 1994
Endotoxin "priming" potentiates lung vascular abnormalities in response to Escherichia coli hemolysin: an example of synergism between endo- and exotoxinD Walmrath, H A Ghofrani, S Rosseau, et al.
Pageof 46